Literature DB >> 33194867

Leucocytosis and Stroke in a Lung Cancer Patient.

Neha Akkad1, Yang Jiang2, Daniel Shin2.   

Abstract

Significant leucocytosis in the setting of an underlying malignancy may be attributed to several causes and is not uncommon; however, extreme leucocytosis (>50×109 cells/l) and hypereosinophilia is less common and may represent a paraneoplastic syndrome. The underlying mechanism is thought to be bone marrow stimulation by tumour-produced cytokines, most notably interleukin-5 (IL-5) and granulocyte-macrophage colony-stimulating factor (GM-CSF). This paraneoplastic syndrome is likely reflective of extensive disease and dissemination, and options for treatment are limited but include tumour resection, corticosteroids and hydroxyurea. In this report, we discuss an unusual case of known stage III lung adenocarcinoma presenting with an ischaemic stroke and extreme leucocytosis and hypereosinophilia. LEARNING POINTS: To illustrate an unusual presentation of progression of non-small-cell lung adenocarcinoma.To highlight the prognostic significance of extreme leucocytosis and hypereosinophilia in patients with an underlying malignancy. © EFIM 2020.

Entities:  

Keywords:  Haematology/oncology; eosinophilia; leucocytosis; non-small-cell lung cancer

Year:  2020        PMID: 33194867      PMCID: PMC7655007          DOI: 10.12890/2020_001872

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  9 in total

Review 1.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma.

Authors:  I Kasuga; S Makino; H Kiyokawa; H Katoh; Y Ebihara; K Ohyashiki
Journal:  Cancer       Date:  2001-11-01       Impact factor: 6.860

3.  Pulmonary lymphangitis carcinomatosis: systematic review and meta-analysis of case reports, 1970-2018.

Authors:  Monika Klimek
Journal:  Postgrad Med       Date:  2019-04-05       Impact factor: 3.840

4.  Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome.

Authors:  Renu Pandit; Aaron Scholnik; Louis Wulfekuhler; Nikolay Dimitrov
Journal:  Am J Hematol       Date:  2007-03       Impact factor: 10.047

5.  Metastatic Lung Adenocarcinoma Presenting with Hypereosinophilia.

Authors:  Omar Abughanimeh; Mohammad Tahboub; Mouhanna Abu Ghanimeh
Journal:  Cureus       Date:  2018-06-22

6.  Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study.

Authors:  John M Granger; Dimitrios P Kontoyiannis
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

7.  Leukemoid reaction in a patient with adenocarcinoma of the lung: a case report.

Authors:  Hendrik Riesenberg; Frauke Müller; Martin Görner
Journal:  J Med Case Rep       Date:  2012-07-19

8.  Rapidly evolving asymptomatic eosinophilia in a patient with lung adenocarcinoma causes cognitive disturbance and respiratory insufficiency: Case report.

Authors:  Cheng-Hsiang Lo; Yee-Min Jen; Wen-Chiuan Tsai; Ping-Ying Chung; Woei-Yau Kao
Journal:  Oncol Lett       Date:  2012-11-09       Impact factor: 2.967

9.  Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer.

Authors:  Antoine Schernberg; Laura Mezquita; Angela Boros; Angela Botticella; Caroline Caramella; Benjamin Besse; Alexandre Escande; David Planchard; Cécile Le Péchoux; Eric Deutsch
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

  9 in total
  2 in total

1.  Case Report: Hematologic Recovery Following Stereotactic Ablative Radiotherapy in a Patient With Early-Stage Non-Small Cell Lung Cancer and Paraneoplastic Myelofibrosis.

Authors:  Lindsey Sloan; Rakhi P Naik; Kavita Umrau; Rena Ruiyu Xian; Kristen A Marrone; Khinh Ranh Voong
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

2.  Tumor-associated eosinophilia in a patient with EGFR-positive, MET-amplified lung adenocarcinoma refractory to targeted therapy: a case report and review of literature.

Authors:  Nan Geng; Wenxia Hu; Hui Ge; Shaonan Xie; Cuimin Ding
Journal:  Transl Cancer Res       Date:  2021-11       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.